Bimn section requires tritiated compounds in order to needed for binding experiments to investigate how novel receptors bind in vivo.

Ended Purchase Order Awarded Last action

Contract number
75N95025P00311
Awardee
Awarding agency
Obligated
$16,650

Award facts

Contract value 100% obligated
$16,650.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325199 All Other Basic Organic Chemical Manufacturing
PSC
6810 Chemicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21224, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work will be completed by August 1, 2025, and supports NIDA's research efforts focused on understanding the mechanisms of drug abuse and addiction.

Quick answers

Who was awarded contract 75N95025P00311?

75N95025P00311 was awarded to Novandi Chemistry AB by National Institute on Drug Abuse (National Institutes of Health) on July 2, 2025.

How much is contract 75N95025P00311 worth?

The government has obligated $16,650 on 75N95025P00311.

Was contract 75N95025P00311 competed?

The extent of competition for 75N95025P00311 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award